Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News OWC Pharmaceuticals Research Corporation (EM) OWCP

OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing... see more

Recent & Breaking News (EXPM:OWCP)

OWC Pharmaceutical Research Corp. Announces A New Distribution Agreement With Can It Industries, Florida US

PR Newswire September 14, 2020

OWC Pharmaceutical Research Corp. Letter to Shareholders for Upcoming Proxy Voting

PR Newswire August 19, 2020

OWC Pharmaceutical Research Corp. Announces Special Meeting of Stockholders

PR Newswire July 29, 2020

OWC Israel's Patent for Cannabis Based Extracts and Topical Formulations for Use in Skin Disorders, Is Allowed for Issuance as a Patent in the USA

PR Newswire December 16, 2019

OWC Pharmaceutical Research Corp and STENOCARE to Enter Partnership to Develop Advanced Medical Cannabis Products

PR Newswire November 14, 2019

OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR) for a Safety Study on Its Cannabis-based Tablets

PR Newswire October 7, 2019

OWC Pharmaceutical Research Received a Permit for a Cannabis Based Ointment Efficacy Trial

PR Newswire August 5, 2019

OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on Its Cannabis-Based Tablets

Business Wire March 27, 2019

OWC Pharmaceutical Research Corp, Letter to Shareholders

PR Newswire February 11, 2019

OWC Pharmaceutical Research Corp. Reports Positive Safety Data From Phase 1 (Safety) Clinical Trial for Medical Grade Cannabis Ointment for Treatment of Skin Diseases

PR Newswire January 30, 2019

OWC Pharmaceutical Research Corp. to Report Progress on Ointment Care for Skin Diseases

PR Newswire December 31, 2018

OWC Pharmaceutical Research Corp. to Attend Biotech Showcase 2019

PR Newswire December 27, 2018

OWC Pharmaceutical Research Corp. Reports the Successful Production of Its Cannabinoid-Enriched Sublingual Disintegrating Tablet

PR Newswire December 18, 2018

OWC Pharmaceutical Research Corp. to Report Progress in Clinical Trials for Ointment Care for Skin Diseases

PR Newswire November 29, 2018

OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy

PR Newswire Europe Non Regulatory November 6, 2018

OWC Pharmaceutical Research Corp Successfully Tests Unique, Innovative Delivery Formulation Aimed at Multiple Myeloma Therapy

PR Newswire October 22, 2018

OWC Pharmaceutical Research Corp Announced Personnel Changes

PR Newswire August 21, 2018

OWC Pharmaceutical Research Corp Initiated Final Stage of Cannabinoid-based Topical Ointment Safety Study

PR Newswire August 1, 2018

OWC Pharmaceutical Research Corp Letter to Shareholders

PR Newswire July 24, 2018

OWC Pharmaceutical Research Corp. Completes First Part of Cannabis-Based Ointment Safety Study

PR Newswire June 29, 2018